<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for HPTX</title>
    <link />
    <description>Headlines for Hyperion Therapeutics</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Benzinga's Top Pre-Market Losers</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3607097/benzingas-top-pre-market-losers.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 21 May 2013 08:21:41 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Rising on Unusual Volume</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/5-stocks-rising-unusual-volume.html-11.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 20 May 2013 05:41:00 GMT</pubDate>
    </item>
    <item>
      <title>Hyperion Therapeutics Becomes Oversold (HPTX)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11911078/1/hyperion-therapeutics-becomes-oversold-hptx.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 01 May 2013 12:48:00 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's Top Initiations</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/initiation/13/04/3478208/benzingas-top-initiations.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 08 Apr 2013 09:01:16 GMT</pubDate>
    </item>
    <item>
      <title>3 Stocks to Get on Your Watchlist</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/13/3-stocks-to-get-on-your-watchlist-25/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 13 Mar 2013 22:25:00 GMT</pubDate>
    </item>
    <item>
      <title>Hyperion Therapeutics Closes Follow-On Offering, Underwriters' Exercised Option</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3414263/hyperion-therapeutics-closes-follow-on-offering-underwriters-exercised-option.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 13 Mar 2013 16:06:59 GMT</pubDate>
    </item>
    <item>
      <title>U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130227-000406&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Wed, 27 Feb 2013 09:09:00 GMT</pubDate>
    </item>
    <item>
      <title>U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130227-000321&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Wed, 27 Feb 2013 06:56:59 GMT</pubDate>
    </item>
    <item>
      <title>Three Companies Disclose Plans to Offer Stock</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130226-000687&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Tue, 26 Feb 2013 19:53:00 GMT</pubDate>
    </item>
    <item>
      <title>Best-Performing Russell 3000 Stocks Year To Date</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1173391-best-performing-russell-3000-stocks-year-to-date.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 11 Feb 2013 18:38:38 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/09/this-week-in-biotech-14/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 09 Feb 2013 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Hyperion Surges on FDA Approval, but What's Next?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/04/hyperion-surges-on-fda-approval-but-whats-next/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 04 Feb 2013 15:07:00 GMT</pubDate>
    </item>
    <item>
      <title>Hyperion Confirms FDA Approval for RAVICITI</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3297905/hyperion-confirms-fda-approval-for-raviciti.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 01 Feb 2013 15:01:52 GMT</pubDate>
    </item>
    <item>
      <title>Market Bets On Approval For Hyperion's Ravicti On FDA's 'Hint'</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1131071-market-bets-on-approval-for-hyperion-s-ravicti-on-fda-s-hint.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 24 Jan 2013 13:07:57 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/19/this-week-in-biotech-12/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 19 Jan 2013 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Why Hyperion Is Poised to Pull Back</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/18/why-hyperion-is-poised-to-pull-back/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 18 Jan 2013 15:27:00 GMT</pubDate>
    </item>
    <item>
      <title>1 Biotech Goes Hyper</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/16/1-biotech-goes-hyper/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 16 Jan 2013 16:12:00 GMT</pubDate>
    </item>
    <item>
      <title>Mid-Day Market Movers</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/01/3248749/mid-day-market-movers.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 16 Jan 2013 11:58:42 GMT</pubDate>
    </item>
    <item>
      <title>FDA Will Not Meet PDUFA Date for Hyperion's Ravicti</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/01/3247881/fda-will-not-meet-pdufa-date-for-hyperions-ravicti.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 16 Jan 2013 08:58:55 GMT</pubDate>
    </item>
    <item>
      <title>Hyperion's Drug Ravicti Likely To Receive FDA Approval</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1102691-hyperion-s-drug-ravicti-likely-to-receive-fda-approval.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 09 Jan 2013 11:30:21 GMT</pubDate>
    </item>
  </channel>
</rss>
